Cargando…
What can we learn from Israel’s rapid roll out of COVID 19 vaccination?
Israel has led the world in rolling out its COVID-19 vaccination program. This experience provides lessons that others can learn from. It is, however, necessary to consider some national specificities, including the small size of the country, its young population, and the political imperative to dri...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835666/ https://www.ncbi.nlm.nih.gov/pubmed/33499901 http://dx.doi.org/10.1186/s13584-021-00441-5 |
_version_ | 1783642579588349952 |
---|---|
author | McKee, Martin Rajan, Selina |
author_facet | McKee, Martin Rajan, Selina |
author_sort | McKee, Martin |
collection | PubMed |
description | Israel has led the world in rolling out its COVID-19 vaccination program. This experience provides lessons that others can learn from. It is, however, necessary to consider some national specificities, including the small size of the country, its young population, and the political imperative to drive this program forward. Israel also has a number of other advantages, including a strong public health infrastructure. The lessons that can be learnt include the importance of coordinating delivery mechanisms with the inevitable prioritisation of groups within the population, timely deployment of a skilled cadre of health workers, a recognition that not everyone in the population shares in the benefits of digital connectedness, the need to reach out to disadvantaged groups, based on an understanding of the barriers that they face, and the importance of placing COVID-19 vaccination within a comprehensive response to the pandemic. |
format | Online Article Text |
id | pubmed-7835666 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78356662021-01-26 What can we learn from Israel’s rapid roll out of COVID 19 vaccination? McKee, Martin Rajan, Selina Isr J Health Policy Res Commentary Israel has led the world in rolling out its COVID-19 vaccination program. This experience provides lessons that others can learn from. It is, however, necessary to consider some national specificities, including the small size of the country, its young population, and the political imperative to drive this program forward. Israel also has a number of other advantages, including a strong public health infrastructure. The lessons that can be learnt include the importance of coordinating delivery mechanisms with the inevitable prioritisation of groups within the population, timely deployment of a skilled cadre of health workers, a recognition that not everyone in the population shares in the benefits of digital connectedness, the need to reach out to disadvantaged groups, based on an understanding of the barriers that they face, and the importance of placing COVID-19 vaccination within a comprehensive response to the pandemic. BioMed Central 2021-01-26 /pmc/articles/PMC7835666/ /pubmed/33499901 http://dx.doi.org/10.1186/s13584-021-00441-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Commentary McKee, Martin Rajan, Selina What can we learn from Israel’s rapid roll out of COVID 19 vaccination? |
title | What can we learn from Israel’s rapid roll out of COVID 19 vaccination? |
title_full | What can we learn from Israel’s rapid roll out of COVID 19 vaccination? |
title_fullStr | What can we learn from Israel’s rapid roll out of COVID 19 vaccination? |
title_full_unstemmed | What can we learn from Israel’s rapid roll out of COVID 19 vaccination? |
title_short | What can we learn from Israel’s rapid roll out of COVID 19 vaccination? |
title_sort | what can we learn from israel’s rapid roll out of covid 19 vaccination? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835666/ https://www.ncbi.nlm.nih.gov/pubmed/33499901 http://dx.doi.org/10.1186/s13584-021-00441-5 |
work_keys_str_mv | AT mckeemartin whatcanwelearnfromisraelsrapidrolloutofcovid19vaccination AT rajanselina whatcanwelearnfromisraelsrapidrolloutofcovid19vaccination |